HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Tuesday, 5 April 2011

Recent cost-utility analyses

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 10 papers were listed this time. Here's a handful:

Greving J, Visseren F, de Wit G, et al. Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis. BMJ.  2011 Mar 30;342:d1672. PubMed PMID: 21450800.

Longworth L, Sculpher MJ, Bojke L, Tosh JC. Bridging the gap between methods research and the needs of policy makers: A review of the research priorities of the National Institute for Health and Clinical Excellence. Int J Technol Assess Health Care. 2011 Mar 29:1-8. [Epub ahead of print] PubMed PMID: 21447260.

Goossens LM, Nivens MC, Sachs P, et al. Is the EQ-5D responsive to recovery from a moderate COPD exacerbation? Respir Med. 2011 Mar 23. [Epub ahead of print] PubMed PMID: 21439807.

Le QA, Doctor JN. Probabilistic Mapping of Descriptive Health Status Responses Onto Health State Utilities Using Bayesian Networks: An Empirical Analysis Converting SF-12 Into EQ-5D Utility Index in a National US Sample. Med Care. 2011 Mar 18. [Epub ahead of print] PubMed PMID: 21422961.